MiRNA-133a is involved in the regulation of postmenopausal osteoporosis through promoting osteoclast differentiation

Evaluation of MicroRNA 125b as a potential biomarker for postmenopausal osteoporosis

(2017) Hua Chen et al.   TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH

Identification of miR-194-5p as a potential biomarker for postmenopausal osteoporosis

(2015) Jia Meng et al.   PeerJ

Plasma miRNA levels correlate with sensitivity to bone mineral density in postmenopausal osteoporosis patients

(2014) Hongqiu Li et al.   BIOMARKERS

The Effects of Amicar and TXA on Lumbar Spine Fusion in an Animal Model

(2014) Jason M. Cuellar et al.   SPINE

China’s Rapidly Aging Population Creates Policy Challenges In Shaping A Viable Long-Term Care System

(2013) Zhanlian Feng et al.   HEALTH AFFAIRS

Prevention and treatment of postmenopausal osteoporosis

(2013) Sri Harsha Tella et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Norisoboldine Suppresses Osteoclast Differentiation through Preventing the Accumulation of TRAF6-TAK1 Complexes and Activation of MAPKs/NF-κB/c-Fos/NFATc1 Pathways

(2013) Zhi-feng Wei et al.   PLoS One

Osteoporosis in Postmenopausal Women

(2013) Suzanne Sanders et al.   SOUTHERN MEDICAL JOURNAL

Ginsenoside Rb1 inhibits osteoclastogenesis by modulating NF-κB and MAPKs pathways

(2012) Binbin Cheng et al.   FOOD AND CHEMICAL TOXICOLOGY

miRNA-34c regulates Notch signaling during bone development

(2012) Yangjin Bae et al.   HUMAN MOLECULAR GENETICS

Expression profiling of microRNAs in RAW264.7 cells treated with a combination of tumor necrosis factor alpha and RANKL during osteoclast differentiation

(2012) T. Kagiya et al.   JOURNAL OF PERIODONTAL RESEARCH

MiR-133a in Human Circulating Monocytes: A Potential Biomarker Associated with Postmenopausal Osteoporosis

(2012) Yang Wang et al.   PLoS One

A microRNA expression signature of osteoclastogenesis

(2011) T. Sugatani et al.   BLOOD

A program of microRNAs controls osteogenic lineage progression by targeting transcription factor Runx2

(2011) Y. Zhang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Ibandronate promotes osteogenic differentiation of periodontal ligament stem cells by regulating the expression of microRNAs

(2010) Qiang Zhou et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

The unitary model for estrogen deficiency and the pathogenesis of osteoporosis: Is a revision needed?

(2010) Sundeep Khosla et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Ethyl Acetate Fraction from Cudrania Tricuspidata Inhibits IL-1β-Stimulated Osteoclast Differentiation through Downregulation of MAPKs, c-Fos and NFATc1

(2010) Eun-Gyeong Lee et al.   KOREAN JOURNAL OF INTERNAL MEDICINE

Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia

(2008) Makoto Tanaka et al.   BONE

Utility of Biochemical Markers of Bone Turnover and Bone Mineral Density in Management of Osteoporosis

(2008) Samuel D. Vasikaran   CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES

Impaired Micro-RNA Pathways Diminish Osteoclast Differentiation and Function

(2008) Toshifumi Sugatani et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

(2008) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL